glp-1 for autoimmune disease medicines may cut clot-related risks in chronically inflamed patients GLP-1 Medications for Arthritis &

Description

Most patients experience increased urination during the first 4 to 8 weeks of semaglutide treatment as their bodies adjust to the medication

NIDDK Meal Timing Article [8] National Heart, Lung, and Blood Institute

One article found an increased incidence of aspiration pneumonia among GLP-1 users compared to non-users reporting a hazard ratio of 1.33 (95%CI 1.021.74, p = 0.036) (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)

Nixons research has been funded through multiple sources including private/local foundations and state contracts/allocations

These trials have shown reductions in heart failure symptoms and physical limitations and greater improvement in exercise function and have led to growing interest in new ways to address HFpEF, a condition with limited guideline direct medication therapy compared to heart failure with reduced ejection fraction (HFrEF)